DBS Group stock downgraded to Hold after 2025 rally; fully priced valuation, softer SORA rates and Q4 risks limit upside—read the outlook now.

Global wealth is on the rise, with the number of high net worth individuals (HNWIs) growing by 4.4% in 2024 to reach 2,341,378. According to The Wealth Report 2025 by Douglas Elliman and Knight Frank, ...

DBS shares are hitting record highs, but for long-term investors, the real question is whether selling now helps or hurts future returns. The post DBS Is at an All-Time High. Should I Sell Now?

Deep brain stimulation (DBS) is a treatment for various neurological conditions such as Parkinson’s disease and obsessive-compulsive disorder. It involves surgically implanting an electrode into your ...

DBS Group posted another year of record earnings in 2024, fueled by resilient net interest income, solid asset quality and excellent fee income growth. The bank continues to sit on a large capital ...

Deep brain stimulation (DBS) involves stimulating certain parts of your brain with implanted electrodes. It’s a promising treatment for treatment-resistant OCD. The main treatments for OCD are talk ...

Nimish Panchmatia, chief data & transformation officer at DBS, elaborates on how the Singaporean bank effectively leverages AI, with a focus on purpose and empathy. Global Finance: How does DBS’ ...

When she greets Euromoney in the bank’s headquarters this summer, Tan Su Shan comes straight from meeting an important client. The client is heavily affected by the fallout from Donald Trump’s trade ...

When she greets Euromoney in the bank’s headquarters this summer, Tan Su Shan comes straight from meeting an important client. The client is heavily affected by the fallout from Donald Trump’s trade ...